Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo
Research use only24h dispatchLot-tracked COA

VaultLabs research guide

Oxytocin research guide

Oxytocin is a disulfide-bridged cyclic nonapeptide, and that bridge governs almost everything a receiving laboratory should care about: which related substances the certificate ought to resolve, which buffer components to keep away from it, and why a mass that looks approximately right is not sufficient evidence of identity. It is also a licensed obstetric medicine internationally, which is a separate product from what VaultLabs supplies. Material is catalogued as Oxytocin 10 mg for in vitro research only; identity and literature context sit on the oxytocin monograph.

Featured materials

In the catalogue

The bridge decides what the certificate must show

A six-residue ring closed by a disulfide bond between two cysteines defines this molecule's conformation. Break that bond and you have the reduced linear form; let thiol exchange occur and you have a scrambled species. Either outcome can still present a mass in the right region while being a different thing from what the protocol names.

So a main-peak percentage is not an adequate release statement here. The related substances worth resolving explicitly are the reduced linear form and disulfide-scrambled species, and a certificate that reports neither is describing less than the method could. How to read a peptide COA covers how to work through the analytical block; the compound-specific point is simply to look for those two entries by name.

The handling rule follows directly. Keep reducing agents and thiol-containing buffer components away from the material unless the design specifically requires them, and treat buffer composition as part of the experimental design rather than as neutral background.

A licensed medicine with the same name is not this material

Oxytocin is a licensed medicine in obstetric practice in the UAE and internationally. That product is manufactured, released and distributed as a pharmaceutical. VaultLabs supplies a research reference material that is none of those things and is not for human or veterinary use.

Record it that way. The name collision is more complete here than for most of the catalogue — same active name, same spelling, entirely different supply chain — so the classification on a requisition and in an inventory system is doing real work. An institutional reviewer who sees only the compound name will reasonably assume the pharmaceutical unless the record says otherwise.

Read the behavioural literature carefully

The classical physiological literature on this peptide is old and well established. The modern behavioural literature is not in the same condition. Reproducibility problems in that area are widely acknowledged, effect sizes have frequently shrunk under replication, and a large volume of secondary writing repeats findings that did not survive.

For a laboratory writing an internal justification, the practical advice is to cite the structural and receptor-level work you can retrieve and to avoid leaning on the popular behavioural summaries. VaultLabs takes no position on those debates and makes no claims about effects of any kind. Where a comparison against another sequence is the actual question, oxytocin versus Semax frames it as identity rather than outcome.

Note also that oxytocin differs from vasopressin at only two of nine positions. That closeness is a reason to treat identity confirmation as a real step rather than a formality, particularly in a laboratory that holds related sequences.

Receiving, diluents and storage

Reconcile invoice SKU, printed name and mass, vial lot and certificate lot before opening. Published records resolve through batch verification and the oxytocin certificate index; pending lots go through documentation request with the status written into the receiving log.

Diluent choice belongs in the record. Bacteriostatic and sterile presentations are catalogued separately under research support reagents — for example sterile water — and the difference between them is explained in bacteriostatic water versus sterile water. Procurement context for consumables is on the research supplies UAE page.

Aqueous preparations of this peptide have a limited practical lifetime, so prepare close to the point of use and do not carry the certified figure forward to a stored solution. Sealed vials are held cold, protected from light and moisture, with equilibration before opening; compound notes are on the oxytocin storage guide and the regional receiving argument is in the UAE climate storage guide.

Frequently asked questions

No. That is a licensed pharmaceutical product with its own manufacturing and release chain. VaultLabs supplies a research reference material for in vitro laboratory use only, and the shared name does not make them interchangeable.

The reduced linear form and disulfide-scrambled species. Both can appear approximately correct by mass while having lost the ring conformation that defines the molecule.

Reducing agents and thiol-containing components, unless the design specifically calls for them, because they drive reduction or exchange at the disulfide bridge. Treat buffer composition as part of the design.

Less time than laboratories often assume, which is why preparation close to the point of use and logged diluent, date and thaw cycles are the relevant controls. The certified purity applies to the lyophilised lot at release, not to a stored preparation.

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.